We have the experience you need to answer key business questions at each stage of brand development
Sickle cell disease (SCD) disproportionately affects underserved and historically marginalized communities, where many patients and caregivers have fallen out of regular care, resulting in gaps in treatment...
Our client faced high discontinuation rates among pediatric patients with a rare liver disease despite demonstrated clinical benefits. They needed to understand the caregiver decision-making factors leading...
Our client in the ophthalmology space was launching a specialized treatment for a rare eye condition The client needed to understand how to approach eyecare professionals across...
A pharmaceutical company was developing a gene therapy for a rare sleep disorder Gene therapy represents paradigm shift requiring understanding of physician readiness for innovation The client...
